An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression.
Das S, Wang W, Ganesan M, Fonseca-Lanza F, Cobb DA, Bybee G, Sun Y, Guo L, Hanson B, Cohen SM, Gendelman HE, Osna NA, Edagwa BJ, Poluektova LY.
Das S, et al. Among authors: cobb da.
Sci Adv. 2022 Dec 23;8(51):eade9582. doi: 10.1126/sciadv.ade9582. Epub 2022 Dec 23.
Sci Adv. 2022.
PMID: 36563152
Free PMC article.